5,477
edits
Delaware weight loss: Difference between revisions
no edit summary
(CSV import) Tags: Mobile edit Mobile web edit |
No edit summary |
||
| Line 1: | Line 1: | ||
Delaware | {{Short description|Delaware weight loss options including obesity statistics, overweight trends, GLP-1 injections, medical weight loss, telemedicine, nutrition counseling, sleep medicine, and W8MD support}} | ||
{{DISPLAYTITLE:Delaware weight loss}} | |||
{{Infobox medical intervention | |||
| name = Delaware weight loss | |||
| image = W8md weight loss sleep and medspa team.jpeg | |||
| caption = W8MD Weight Loss, Sleep and MedSpa helps Delaware residents with physician-supervised medical weight loss, GLP-1 injections, nutrition counseling, sleep medicine, and telemedicine options when appropriate | |||
| specialty = [[Obesity medicine]], [[medical weight loss]], [[nutrition counseling]], [[sleep medicine]], [[lifestyle medicine]] | |||
| uses = [[Obesity]], [[overweight]], [[weight loss]], [[weight loss maintenance]], [[insulin resistance]], [[prediabetes]], [[type 2 diabetes]], [[sleep apnea]], [[metabolic syndrome]], [[hypertension]] | |||
| methods = [[GLP-1 weight loss injections]], [[Semaglutide]], [[Tirzepatide]], prescription [[diet pills]], [[nutrition counseling]], [[meal replacements]], [[exercise counseling]], [[sleep apnea]] care, [[telemedicine]] | |||
| providers = [[Physician]], [[obesity medicine physician]], [[bariatrician]], [[nurse practitioner]], [[sleep medicine physician]] | |||
| related = [[W8MD Weight Loss, Sleep and MedSpa]], [[Philadelphia weight loss doctor]], [[Delaware County PA weight loss]], [[Greater Philadelphia weight loss]], [[weight loss maintenance]] | |||
}} | |||
[[File:W8MD-Team.jpeg|thumb|right|350px|[[W8MD Weight Loss, Sleep and MedSpa]] helps Delaware patients with physician-supervised medical weight loss, sleep medicine, nutrition counseling, and long-term maintenance.]] | |||
[[File:Ozempic® 3ml.jpg|Ozempic®_3ml|thumb|right|300px|W8MD's Greater Philadelphia GLP-1 weight loss clinic.]] | |||
[[File:W8MD GLP-1 weight loss injections.jpeg|thumb|right|300px|Affordable [[GLP-1 weight loss injections]] may be available for eligible W8MD patients when medically appropriate.]] | |||
[[File:Before-and-after-weight-loss.jpeg|thumb|right|300px|Successful [[weight loss]] requires a plan for both active weight loss and [[weight loss maintenance]].]] | |||
[[File:Weight-loss-success-stories-1.jpeg|thumb|right|300px|W8MD success stories include patients who lost substantial weight and maintained long-term results.]] | |||
[[File:Woman-losing-weight.jpeg|thumb|right|350px|W8MD may combine [[Semaglutide]], [[Tirzepatide]], traditional prescription medications, nutrition counseling, and lifestyle medicine.]] | |||
[[File:W8md-meal-replacementnts.png|thumb|right|350px|[[Meal replacements]] may help selected patients with portion control, protein intake, low-carbohydrate meal planning, and structure.]] | |||
[[File:Sleep-apnea.png|thumb|right|350px|W8MD also evaluates and treats [[sleep apnea]], which can worsen hunger, fatigue, insulin resistance, hypertension, and weight regain.]] | |||
'''Delaware weight loss''' refers to medical, nutritional, behavioral, medication-based, physical activity, sleep, and telemedicine-supported strategies used to help residents of [[Delaware]] lose weight safely and maintain results long term. Delaware is a small but densely populated Mid-Atlantic state with three counties: [[New Castle County, Delaware|New Castle County]], [[Kent County, Delaware|Kent County]], and [[Sussex County, Delaware|Sussex County]]. Major communities include [[Wilmington, Delaware|Wilmington]], [[Dover, Delaware|Dover]], [[Newark, Delaware|Newark]], [[Middletown, Delaware|Middletown]], [[Bear, Delaware|Bear]], [[Smyrna, Delaware|Smyrna]], [[Milford, Delaware|Milford]], [[Georgetown, Delaware|Georgetown]], [[Lewes, Delaware|Lewes]], [[Rehoboth Beach, Delaware|Rehoboth Beach]], and [[Seaford, Delaware|Seaford]]. | |||
'''[[W8MD Weight Loss, Sleep and MedSpa]]''' helps Delaware patients with physician-supervised [[medical weight loss]], affordable [[GLP-1 weight loss injections]], prescription [[diet pills]], [[nutrition counseling]], [[meal replacements]], [[exercise counseling]], [[sleep apnea]] screening and treatment, [[lifestyle medicine]], [[telemedicine]] visits when appropriate, and long-term [[weight loss maintenance]]. W8MD’s Greater Philadelphia office is located at '''1718 Welsh Road, 2nd Floor, Suite C, Philadelphia, PA 19115''', phone '''(215) 676-2334''', and may be convenient for Delaware residents in northern Delaware, Wilmington, Newark, Bear, Middletown, and surrounding areas.{{cite web|url=https://w8md.org/|title=W8MD Weight Loss, Sleep & MedSpa|publisher=W8MD|accessdate=July 5, 2026}} | |||
==Overview== | |||
Weight management is a major public health issue in Delaware. [[Obesity]] is associated with increased risk of [[type 2 diabetes]], [[prediabetes]], [[hypertension]], [[sleep apnea]], [[heart disease]], [[stroke]], [[fatty liver disease]], [[osteoarthritis]], some cancers, reduced mobility, and increased health-care costs. | |||
According to America's Health Rankings, Delaware’s adult obesity prevalence was '''36.6%''' in 2024, above the U.S. value of 34.2% in that dataset.{{cite web|url=https://www.americashealthrankings.org/explore/measures/Obesity/DE|title=Explore Obesity in Delaware|publisher=America's Health Rankings|accessdate=July 5, 2026}} CDC 2024 BRFSS maps reported that all U.S. states and territories had adult obesity prevalence of at least 25%, with the Northeast region at 30.3% overall.{{cite web|url=https://www.cdc.gov/obesity/data-and-statistics/adult-obesity-prevalence-maps.html|title=Adult Obesity Prevalence Maps|publisher=Centers for Disease Control and Prevention|date=December 3, 2025|accessdate=July 5, 2026}} | |||
A Delaware Division of Public Health data brief reported that in 2022, '''37.9%''' of Delaware adults reported obesity and another '''33.9%''' reported BMI levels considered overweight, meaning more than 7 in 10 adults were above the recommended weight range.{{cite web|url=https://dhss.delaware.gov/wp-content/uploads/sites/12/dph/pdf/2022DelawarePhysicalActivity-NutritionAndObesityDS.pdf|title=One in Three Delaware Adults Reports Being Obese|publisher=Delaware Health and Social Services, Division of Public Health|accessdate=July 5, 2026}} | |||
==Why Delaware needs medical weight loss== | |||
Delaware’s obesity and overweight burden is not simply a cosmetic issue. Excess weight is linked to metabolic, cardiovascular, respiratory, orthopedic, and mental health consequences. | |||
Important Delaware-related statistics include: | |||
{| class="wikitable" | |||
! Measure | |||
! Delaware statistic | |||
! Source | |||
|- | |||
| Adult obesity | |||
| 36.6% in 2024 | |||
| America's Health Rankings, BRFSS 2024{{cite web|url=https://www.americashealthrankings.org/explore/measures/Obesity/DE|title=Explore Obesity in Delaware|publisher=America's Health Rankings|accessdate=July 5, 2026}} | |||
|- | |||
| Adult obesity | |||
| 37.9% in 2022 | |||
| Delaware Division of Public Health BRFS data brief{{cite web|url=https://dhss.delaware.gov/wp-content/uploads/sites/12/dph/pdf/2022DelawarePhysicalActivity-NutritionAndObesityDS.pdf|title=One in Three Delaware Adults Reports Being Obese|publisher=Delaware Health and Social Services, Division of Public Health|accessdate=July 5, 2026}} | |||
|- | |||
| Adult overweight | |||
| 33.9% in 2022 | |||
| Delaware Division of Public Health BRFS data brief{{cite web|url=https://dhss.delaware.gov/wp-content/uploads/sites/12/dph/pdf/2022DelawarePhysicalActivity-NutritionAndObesityDS.pdf|title=One in Three Delaware Adults Reports Being Obese|publisher=Delaware Health and Social Services, Division of Public Health|accessdate=July 5, 2026}} | |||
|- | |||
| Adult overweight or obesity | |||
| About 71.8% in 2022, combining overweight and obesity categories | |||
| Calculated from Delaware DPH 2022 BRFS obesity and overweight estimates{{cite web|url=https://dhss.delaware.gov/wp-content/uploads/sites/12/dph/pdf/2022DelawarePhysicalActivity-NutritionAndObesityDS.pdf|title=One in Three Delaware Adults Reports Being Obese|publisher=Delaware Health and Social Services, Division of Public Health|accessdate=July 5, 2026}} | |||
|- | |||
| Delaware obesity projection | |||
| Adult obesity projected to increase to 52% by 2030 in one state-focused obesity burden report | |||
| American Diabetes Association Delaware obesity burden report{{cite web|url=https://diabetes.org/sites/default/files/2025-05/the-burden-of-obesity-delaware-05-08-25.pdf|title=Delaware Obesity Epidemic|publisher=American Diabetes Association|date=May 8, 2025|accessdate=July 5, 2026}} | |||
|- | |||
| U.S. adult obesity comparison | |||
| 40.3% of U.S. adults had obesity during August 2021-August 2023 | |||
| CDC National Center for Health Statistics{{cite web|url=https://www.cdc.gov/nchs/products/databriefs/db508.htm|title=Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023|publisher=Centers for Disease Control and Prevention, National Center for Health Statistics|date=September 24, 2024|accessdate=July 5, 2026}} | |||
|} | |||
==Obesity-related conditions in Delaware== | |||
Obesity and overweight may increase risk for: | |||
{{div col|colwidth=18em}} | |||
* [[Type 2 diabetes]] | |||
* [[Prediabetes]] | |||
* [[Insulin resistance]] | |||
* [[Hypertension]] | |||
* [[Dyslipidemia]] | |||
* [[Metabolic syndrome]] | |||
* [[Sleep apnea]] | |||
* [[Fatty liver disease]] | |||
* [[Heart disease]] | |||
* [[Stroke]] | |||
* [[Osteoarthritis]] | |||
* [[PCOS]] | |||
* [[Gastroesophageal reflux disease]] | |||
* [[Depression]] | |||
* Some cancers | |||
{{div col end}} | |||
America's Health Rankings reported Delaware diabetes prevalence at 13.1% in 2024.{{cite web|url=https://www.americashealthrankings.org/explore/measures/Diabetes/DE|title=Explore Diabetes in Delaware|publisher=America's Health Rankings|accessdate=July 5, 2026}} The FDA has also recognized the relationship between obesity and sleep apnea by approving [[Zepbound]] as the first medication for moderate-to-severe obstructive sleep apnea in adults with obesity.{{cite web|url=https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea|title=FDA Approves First Medication for Obstructive Sleep Apnea|publisher=U.S. Food and Drug Administration|date=December 20, 2024|accessdate=July 5, 2026}} | |||
==Delaware communities served by W8MD== | |||
W8MD may help Delaware residents from: | |||
{{div col|colwidth=18em}} | |||
* [[Wilmington, Delaware|Wilmington]] | |||
* [[Newark, Delaware|Newark]] | |||
* [[Bear, Delaware|Bear]] | |||
* [[Middletown, Delaware|Middletown]] | |||
* [[Dover, Delaware|Dover]] | |||
* [[Smyrna, Delaware|Smyrna]] | |||
* [[New Castle, Delaware|New Castle]] | |||
* [[Claymont, Delaware|Claymont]] | |||
* [[Hockessin, Delaware|Hockessin]] | |||
* [[Elsmere, Delaware|Elsmere]] | |||
* [[Glasgow, Delaware|Glasgow]] | |||
* [[Pike Creek, Delaware|Pike Creek]] | |||
* [[Milford, Delaware|Milford]] | |||
* [[Georgetown, Delaware|Georgetown]] | |||
* [[Lewes, Delaware|Lewes]] | |||
* [[Rehoboth Beach, Delaware|Rehoboth Beach]] | |||
* [[Seaford, Delaware|Seaford]] | |||
* [[Laurel, Delaware|Laurel]] | |||
* [[Millsboro, Delaware|Millsboro]] | |||
* [[Dagsboro, Delaware|Dagsboro]] | |||
{{div col end}} | |||
==How W8MD can help Delaware patients== | |||
[[W8MD Weight Loss, Sleep and MedSpa]] provides evidence-based medical weight-loss care that can be individualized for Delaware residents. W8MD does not rely on diet advice alone. Instead, it can combine medical evaluation, medication support, nutrition, sleep care, physical activity, and long-term maintenance. | |||
W8MD may help with: | |||
{{div col|colwidth=20em}} | |||
* [[Medical weight loss]] | |||
* [[Body mass index]] assessment | |||
* Weight-related risk evaluation | |||
* [[GLP-1 weight loss injections]] | |||
* [[Semaglutide]] | |||
* [[Tirzepatide]] | |||
* Prescription [[diet pills]] | |||
* [[Phentermine]] | |||
* [[Contrave]] | |||
* [[Qsymia]] | |||
* [[Diethylpropion]] | |||
* [[Phendimetrazine]] | |||
* [[Metformin]] | |||
* [[Topiramate]] | |||
* [[Orlistat]] | |||
* [[Nutrition counseling]] | |||
* [[Meal replacements]] | |||
* [[Low-carbohydrate diet]] | |||
* [[Ketogenic diet]] | |||
* [[Very low calorie diet]] | |||
* [[Exercise counseling]] | |||
* [[Behavior modification]] | |||
* [[Sleep apnea]] screening | |||
* [[Home sleep test]] | |||
* [[CPAP]] support | |||
* [[Telemedicine]] visits when appropriate | |||
* Long-term [[weight loss maintenance]] | |||
{{div col end}} | |||
==In-person and televisit options== | |||
Delaware residents may benefit from both in-person and telemedicine-supported care. | |||
===In-person care=== | |||
In-person visits may be useful for: | |||
{{div col|colwidth=18em}} | |||
* Initial medical evaluation | |||
* Blood pressure check | |||
* Weight and body composition review | |||
* Medication safety review | |||
* Injectable medication teaching | |||
* Sleep apnea evaluation | |||
* MedSpa and body-contouring services | |||
* Patients who prefer face-to-face care | |||
{{div col end}} | |||
W8MD’s Greater Philadelphia office is accessible to many Delaware residents, especially those in New Castle County and northern Delaware. | |||
===Televisit care=== | |||
Televisit or telemedicine options may be useful for selected patients who cannot travel frequently. | |||
Televisit care may help with: | |||
{{div col|colwidth=18em}} | |||
* Weight-loss follow-up | |||
* Medication monitoring | |||
* GLP-1 side-effect review | |||
* Nutrition counseling | |||
* Meal plan adjustment | |||
* Exercise counseling | |||
* Weight regain prevention | |||
* Sleep symptom review | |||
* Maintenance planning | |||
{{div col end}} | |||
Telemedicine availability depends on the patient’s location, medical condition, state rules, insurance coverage, medication regulations, and clinical judgment. Some patients may still need in-person evaluation, laboratory testing, blood pressure monitoring, or coordination with local clinicians. | |||
==Affordable GLP-1 weight loss options for Delaware== | |||
<div style="border:2px solid #f2c94c;background:#fff8df;padding:16px;margin:14px 0;border-radius:10px;"> | |||
'''Affordable GLP-1 weight-loss options for Delaware residents''' | |||
W8MD offers physician-supervised GLP-1 weight-loss options for eligible patients from Delaware and the Greater Philadelphia region. | |||
* '''Semaglutide starting as low as $29.99/week and up''' with insurance for qualifying medical visits. | |||
* '''Tirzepatide starting as low as $45.00/week and up''' with insurance for qualifying medical visits. | |||
* '''Self-pay GLP-1 options may start from $59.99/week and up''' when available and medically appropriate. | |||
* Most insurances are accepted for qualifying physician-supervised visits when coverage is available. | |||
* Pricing, eligibility, medication access, dosing, insurance coverage, prior authorization, pharmacy availability, telemedicine availability, and program details vary by patient, medication, location, and medical evaluation. | |||
</div> | |||
==GLP-1 weight loss medications== | |||
[[GLP-1 weight loss injections]] and related incretin medications can help eligible patients reduce hunger, increase satiety, reduce cravings, reduce food noise, and improve portion control. | |||
Common options include: | |||
{| class="wikitable" | |||
! Medication | |||
! Brand names | |||
! Type | |||
! W8MD role | |||
|- | |||
| [[Semaglutide]] | |||
| [[Wegovy]], [[Ozempic]] | |||
| [[GLP-1 receptor agonist]] | |||
| May be used for eligible patients when medically appropriate | |||
|- | |||
| [[Tirzepatide]] | |||
| [[Zepbound]], [[Mounjaro]] | |||
| Dual [[GIP]] and [[GLP-1]] receptor agonist | |||
| May be used for eligible patients when medically appropriate | |||
|- | |||
| [[Liraglutide]] | |||
| [[Saxenda]], [[Victoza]] | |||
| GLP-1 receptor agonist | |||
| Alternative injectable option in selected patients | |||
|- | |||
| [[Retatrutide]] | |||
| Investigational | |||
| Triple [[GIP]], [[GLP-1]], and glucagon receptor agonist | |||
| Education and pipeline monitoring only unless legally available | |||
|} | |||
The FDA approved [[Zepbound]] or [[tirzepatide]] for chronic weight management in adults with obesity or overweight with at least one weight-related condition, together with reduced-calorie diet and increased physical activity.{{cite web|url=https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management|title=FDA Approves New Medication for Chronic Weight Management|publisher=U.S. Food and Drug Administration|date=November 8, 2023|accessdate=July 5, 2026}} | |||
The FDA approved [[Wegovy]] or [[semaglutide]] to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight.{{cite web|url=https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or|title=FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight|publisher=U.S. Food and Drug Administration|date=March 8, 2024|accessdate=July 5, 2026}} | |||
==Traditional prescription diet pills== | |||
GLP-1 medications are not the only option. W8MD may offer traditional prescription weight-loss medications when medically appropriate. | |||
Options may include: | |||
{{div col|colwidth=18em}} | |||
* [[Phentermine]] | |||
* [[Phentermine/topiramate]] | |||
* [[Qsymia]] | |||
* [[Contrave]] | |||
* [[Diethylpropion]] | |||
* [[Phendimetrazine]] | |||
* [[Topiramate]] | |||
* [[Metformin]] | |||
* [[Orlistat]] | |||
{{div col end}} | |||
The [[National Institute of Diabetes and Digestive and Kidney Diseases]] lists several prescription medications used to treat overweight and obesity, including [[orlistat]], [[phentermine/topiramate]], [[naltrexone/bupropion]], [[liraglutide]], [[semaglutide]], and [[tirzepatide]].{{cite web|url=https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity|title=Prescription Medications to Treat Overweight and Obesity|publisher=National Institute of Diabetes and Digestive and Kidney Diseases|accessdate=July 5, 2026}} | |||
==Nutrition counseling== | |||
[[Nutrition counseling]] is central to safe weight loss. W8MD can help Delaware patients build a realistic plan instead of relying on short-term dieting. | |||
Nutrition counseling may include: | |||
{{div col|colwidth=18em}} | |||
* Protein-first meals | |||
* Low-carbohydrate meal planning | |||
* [[Ketogenic diet]] | |||
* [[Very low calorie diet]] when medically appropriate | |||
* [[Meal replacements]] | |||
* Diabetes-friendly nutrition | |||
* [[Carbohydrate counting]] | |||
* Restaurant strategies | |||
* Grocery planning | |||
* Hydration planning | |||
* Cultural food planning | |||
* Weight regain prevention | |||
{{div col end}} | |||
The NIDDK recommends selecting a safe weight-loss program that includes healthy eating, physical activity, behavioral strategies, trained staff, medical care when needed, and long-term weight maintenance strategies.{{cite web|url=https://www.niddk.nih.gov/health-information/weight-management/choosing-a-safe-successful-weight-loss-program|title=Choosing a Safe and Successful Weight-loss Program|publisher=National Institute of Diabetes and Digestive and Kidney Diseases|accessdate=July 5, 2026}} | |||
==Meal replacements== | |||
[[Meal replacements]] may help selected Delaware patients by improving structure, portion control, protein intake, and convenience. | |||
Meal replacements may help with: | |||
{{div col|colwidth=18em}} | |||
* Busy schedules | |||
* Skipped meals | |||
* Portion control | |||
* Protein intake | |||
* Low-carbohydrate plans | |||
* GLP-1 patients with low appetite | |||
* Very low calorie diet plans | |||
* Travel days | |||
* Weight regain correction | |||
* Maintenance planning | |||
{{div col end}} | |||
==Exercise counseling== | |||
[[Exercise counseling]] helps Delaware patients use physical activity safely and realistically. Exercise is important for heart health, insulin sensitivity, strength, mobility, mood, sleep, and long-term maintenance. | |||
W8MD exercise counseling may include: | |||
{{div col|colwidth=18em}} | |||
* Walking plans | |||
* Post-meal walking | |||
* Step goals | |||
* [[Strength training]] | |||
* Resistance bands | |||
* Chair exercises | |||
* Low-impact activity | |||
* Joint-friendly movement | |||
* Gradual progression | |||
* Activity planning around work and family schedules | |||
{{div col end}} | |||
The CDC recommends at least 150 minutes of moderate-intensity aerobic activity weekly plus 2 days of muscle-strengthening activity for adults.{{cite web|url=https://www.cdc.gov/physical-activity-basics/guidelines/adults.html|title=Adult Activity: An Overview|publisher=Centers for Disease Control and Prevention|date=December 20, 2023|accessdate=July 5, 2026}} | |||
==Sleep medicine and sleep apnea== | |||
W8MD is also a sleep medicine center. This is especially important because untreated [[sleep apnea]] can worsen fatigue, cravings, insulin resistance, hypertension, and weight regain. | |||
W8MD may help Delaware residents with: | |||
{{div col|colwidth=18em}} | |||
* [[Sleep apnea]] screening | |||
* [[Snoring]] evaluation | |||
* [[Home sleep test]] | |||
* [[CPAP]] | |||
* [[BiPAP]] | |||
* [[APAP]] | |||
* Sleep and weight counseling | |||
* Zepbound evaluation for eligible adults with obesity and moderate-to-severe OSA | |||
{{div col end}} | |||
==Weight loss maintenance== | |||
Long-term success requires a maintenance plan. Many patients lose weight but regain it when follow-up stops, medication access changes, sleep worsens, stress increases, or old eating habits return. | |||
W8MD maintenance care may include: | |||
{{div col|colwidth=20em}} | |||
* Regular follow-up visits | |||
* Televisit follow-up when appropriate | |||
* [[GLP-1 maintenance therapy]] | |||
* Clinician-guided [[microdosing]] discussions when appropriate | |||
* Prescription [[diet pills]] when appropriate | |||
* [[Nutrition counseling]] | |||
* [[Meal replacements]] | |||
* [[Exercise counseling]] | |||
* [[Strength training]] | |||
* [[Sleep apnea]] treatment | |||
* Weekly weight monitoring | |||
* Relapse prevention | |||
* Early treatment of [[weight regain]] | |||
{{div col end}} | |||
The STEP 1 trial extension found that after withdrawal of once-weekly [[semaglutide]] 2.4 mg and lifestyle intervention, participants regained a substantial portion of lost weight.{{cite journal|last1=Wilding|first1=J. P. H.|title=Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension|journal=Diabetes, Obesity and Metabolism|year=2022|pmid=35441470|pmc=9542252}} | |||
The SURMOUNT-4 trial found that continued [[tirzepatide]] helped maintain and increase weight reduction, while medication withdrawal led to substantial regain.{{cite journal|last1=Aronne|first1=L. J.|title=Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity|journal=JAMA|year=2024|pmid=38078870}} | |||
==Why choose W8MD for Delaware weight loss?== | |||
W8MD is a natural choice for Delaware residents seeking physician-supervised weight loss because it combines evidence-based obesity medicine with sleep medicine, nutrition counseling, medications, telemedicine follow-up when appropriate, and long-term support. | |||
Reasons to choose W8MD include: | |||
{{div col|colwidth=20em}} | |||
* Physician-supervised care | |||
* Over 15 years of medical weight-loss experience | |||
* Affordable GLP-1 options | |||
* Semaglutide and Tirzepatide programs | |||
* Traditional prescription diet pills | |||
* Nutrition counseling | |||
* Meal replacement options | |||
* Sleep apnea diagnosis and treatment | |||
* Weight-loss maintenance planning | |||
* Weight regain prevention | |||
* In-person Greater Philadelphia visits | |||
* Televisit options when appropriate | |||
* Most insurances accepted for qualifying visits | |||
* Practical long-term follow-up | |||
{{div col end}} | |||
==W8MD patient success highlight== | |||
W8MD has helped thousands of patients since 2011. Individual results vary, but W8MD success stories include patients who lost more than 100 pounds and maintained long-term results. | |||
<div style="border:2px solid #b7d7a8;background:linear-gradient(135deg,#f7fff3,#ffffff);padding:18px;margin:14px 0 20px 0;border-radius:12px;"> | |||
<h2 style="margin-top:0;color:#38761d;">Fantastic program. Truly a life changer.</h2> | |||
<blockquote style="font-size:112%;line-height:1.7;margin:0;"> | |||
'''“FANTASTIC program! Truly a life changer! The first several months I lost on average 3 pounds a week. I have now lost 87 pounds in 10 months and I'm still losing! I can say it feels almost effortless, for with the elimination of most carbs plus the medication I have ZERO cravings and minimal hunger. My cholesterol, blood pressure, and blood sugar have all returned to normal having previously been considerably elevated. I look and feel twenty years younger (I am 57.) Staff is friendly and supportive, and the science works. I did not think that I would be able to achieve such results, and certainly not in less than a year. I am amazed at my success, and I could not have done it without Dr. Tumpati and W8MD.”''' | |||
</blockquote> | |||
<p style="font-size:105%;line-height:1.6;margin-bottom:0;"> | |||
'''- D.M., actual W8MD patient''' who lost '''100 lbs''' and has maintained the weight loss for over '''10 years'''. Individual results vary. | |||
</p> | |||
</div> | |||
==W8MD Greater Philadelphia location== | |||
{| class="wikitable" style="width:100%;" | |||
! Location | |||
! Address | |||
! Phone | |||
! Services | |||
! Map | |||
|- | |||
| '''[[Philadelphia weight loss doctor|Philadelphia / Greater Philadelphia Weight Loss and MedSpa Center]]''' | |||
| 1718 Welsh Road, 2nd Floor, Suite C, Philadelphia, PA 19115 | |||
| (215) 676-2334 | |||
| [[Medical weight loss]], [[GLP-1 weight loss injections]], [[Semaglutide]], [[Tirzepatide]], [[nutrition counseling]], [[exercise counseling]], [[sleep medicine]], [[MedSpa]], [[weight loss maintenance]], [[telemedicine]] follow-up when appropriate | |||
| [https://www.google.com/maps/search/?api=1&query=1718+Welsh+Road+2nd+Floor+Ste+C+Philadelphia+PA+19115 View map] | |||
|} | |||
==Frequently asked questions== | |||
===Does W8MD help Delaware residents lose weight?=== | |||
Yes. W8MD can help Delaware residents through its Greater Philadelphia medical weight-loss program, including GLP-1 options, traditional diet pills, nutrition counseling, meal replacements, sleep medicine, and long-term maintenance care. | |||
===Does W8MD offer televisits for Delaware patients?=== | |||
W8MD may offer telemedicine or televisit follow-up options when clinically appropriate and permitted by state rules, insurance coverage, and medication regulations. Some patients may still need in-person evaluation. | |||
===What are the latest Delaware obesity statistics?=== | |||
America's Health Rankings reported Delaware adult obesity at 36.6% in 2024. Delaware DPH reported that in 2022, 37.9% of adults had obesity and 33.9% were overweight. | |||
===What GLP-1 shots are available for Delaware patients?=== | |||
Eligible patients may be evaluated for Semaglutide, Tirzepatide, and other medically appropriate GLP-1 or incretin-based options. Medication choice depends on medical history, BMI, insurance, contraindications, availability, and clinician judgment. | |||
===How much do GLP-1 weight loss shots cost at W8MD?=== | |||
W8MD promotional pricing may include Semaglutide starting as low as $29.99/week and up with insurance for qualifying visits and Tirzepatide starting as low as $45.00/week and up with insurance for qualifying visits. Pricing and eligibility vary. | |||
===Does W8MD offer non-GLP-1 weight-loss medications?=== | |||
Yes. W8MD may offer traditional prescription diet pills such as Phentermine, Contrave, Qsymia, Diethylpropion, Phendimetrazine, Topiramate, Metformin, or Orlistat when medically appropriate. | |||
===Can W8MD help with weight regain?=== | |||
Yes. W8MD focuses on long-term weight maintenance, medication adjustment, nutrition counseling, regular follow-up, sleep apnea treatment, exercise counseling, and early intervention for regain. | |||
===Can W8MD help if I have sleep apnea?=== | |||
Yes. W8MD provides sleep apnea screening, home sleep testing, CPAP-related support, and weight-loss care for patients with obesity and sleep apnea risk. | |||
==Conclusion== | |||
Delaware weight loss requires more than short-term dieting. With adult obesity reported at 36.6% in Delaware in 2024 and more than 7 in 10 Delaware adults reported as overweight or obese in 2022, there is a strong need for safe, evidence-based, medically supervised weight management. [[W8MD Weight Loss, Sleep and MedSpa]] can help Delaware residents through in-person Greater Philadelphia visits and telemedicine follow-up when appropriate, combining GLP-1 injections, traditional prescription diet pills, nutrition counseling, meal replacements, exercise counseling, sleep apnea care, behavior modification, and long-term maintenance strategies to help patients lose weight and keep it off. | |||
==See also== | |||
{{div col|colwidth=18em}} | |||
* [[Delaware weight loss]] | |||
* [[Delaware County PA weight loss]] | |||
* [[Greater Philadelphia weight loss]] | |||
* [[Philadelphia weight loss doctor]] | |||
* [[Medical weight loss]] | |||
* [[Obesity medicine]] | |||
* [[GLP-1 weight loss injections]] | |||
* [[Semaglutide]] | |||
* [[Tirzepatide]] | |||
* [[Zepbound]] | |||
* [[Wegovy]] | |||
* [[Diet pills]] | |||
* [[Phentermine]] | |||
* [[Contrave]] | |||
* [[Nutrition counseling]] | |||
* [[Meal replacements]] | |||
* [[Exercise counseling]] | |||
* [[Sleep apnea]] | |||
* [[Telemedicine]] | |||
* [[Weight loss maintenance]] | |||
* [[Weight regain]] | |||
* [[W8MD Weight Loss, Sleep and MedSpa]] | |||
{{div col end}} | |||
==Relevant WikiMD links== | |||
* [https://wikimd.org/wiki/Delaware_weight_loss Delaware weight loss on WikiMD] | |||
* [https://wikimd.org/wiki/Delaware_County_PA_weight_loss Delaware County PA weight loss on WikiMD] | |||
* [https://wikimd.org/wiki/Greater_Philadelphia_weight_loss Greater Philadelphia weight loss on WikiMD] | |||
* [https://wikimd.org/wiki/Philadelphia_weight_loss_doctor Philadelphia weight loss doctor on WikiMD] | |||
* [https://wikimd.org/wiki/Medical_weight_loss Medical weight loss on WikiMD] | |||
* [https://wikimd.org/wiki/GLP-1_weight_loss_injections GLP-1 weight loss injections on WikiMD] | |||
* [https://wikimd.org/wiki/Semaglutide Semaglutide on WikiMD] | |||
* [https://wikimd.org/wiki/Tirzepatide Tirzepatide on WikiMD] | |||
* [https://wikimd.org/wiki/Nutrition_counseling Nutrition counseling on WikiMD] | |||
* [https://wikimd.org/wiki/Sleep_apnea Sleep apnea on WikiMD] | |||
* [https://wikimd.org/wiki/Telemedicine Telemedicine on WikiMD] | |||
* [https://wikimd.org/wiki/Weight_loss_maintenance Weight loss maintenance on WikiMD] | |||
==Further reading== | |||
* {{cite web|url=https://w8md.org/|title=W8MD Weight Loss, Sleep & MedSpa|publisher=W8MD|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://w8mdspa.com/|title=W8MD Weight Loss, Sleep & MedSpa|publisher=W8MD|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://www.americashealthrankings.org/explore/measures/Obesity/DE|title=Explore Obesity in Delaware|publisher=America's Health Rankings|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://www.cdc.gov/obesity/data-and-statistics/adult-obesity-prevalence-maps.html|title=Adult Obesity Prevalence Maps|publisher=Centers for Disease Control and Prevention|date=December 3, 2025|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://dhss.delaware.gov/wp-content/uploads/sites/12/dph/pdf/2022DelawarePhysicalActivity-NutritionAndObesityDS.pdf|title=One in Three Delaware Adults Reports Being Obese|publisher=Delaware Health and Social Services, Division of Public Health|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://diabetes.org/sites/default/files/2025-05/the-burden-of-obesity-delaware-05-08-25.pdf|title=Delaware Obesity Epidemic|publisher=American Diabetes Association|date=May 8, 2025|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://www.cdc.gov/nchs/products/databriefs/db508.htm|title=Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023|publisher=Centers for Disease Control and Prevention, National Center for Health Statistics|date=September 24, 2024|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://www.americashealthrankings.org/explore/measures/Diabetes/DE|title=Explore Diabetes in Delaware|publisher=America's Health Rankings|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity|title=Prescription Medications to Treat Overweight and Obesity|publisher=National Institute of Diabetes and Digestive and Kidney Diseases|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://www.niddk.nih.gov/health-information/weight-management/choosing-a-safe-successful-weight-loss-program|title=Choosing a Safe and Successful Weight-loss Program|publisher=National Institute of Diabetes and Digestive and Kidney Diseases|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://www.cdc.gov/physical-activity-basics/guidelines/adults.html|title=Adult Activity: An Overview|publisher=Centers for Disease Control and Prevention|date=December 20, 2023|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management|title=FDA Approves New Medication for Chronic Weight Management|publisher=U.S. Food and Drug Administration|date=November 8, 2023|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or|title=FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight|publisher=U.S. Food and Drug Administration|date=March 8, 2024|accessdate=July 5, 2026}} | |||
* {{cite web|url=https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea|title=FDA Approves First Medication for Obstructive Sleep Apnea|publisher=U.S. Food and Drug Administration|date=December 20, 2024|accessdate=July 5, 2026}} | |||
* {{cite journal|last1=Wilding|first1=J. P. H.|title=Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension|journal=Diabetes, Obesity and Metabolism|year=2022|pmid=35441470|pmc=9542252}} | |||
* {{cite journal|last1=Aronne|first1=L. J.|title=Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity|journal=JAMA|year=2024|pmid=38078870}} | |||
==External links== | |||
* [https://w8md.org W8MD Philadelphia medical weight loss] | |||
* [https://www.w8mdspa.com W8MD Weight Loss, Sleep and MedSpa Centers] | |||
* [https://nycmedicalweightloss.com NYC medical weight loss] | |||
* [https://wikimd.org/wiki/Delaware_weight_loss Delaware weight loss on WikiMD] | |||
* [https://wikimd.org/wiki/Philadelphia_weight_loss_doctor Philadelphia weight loss doctor on WikiMD] | |||
* [https://wikimd.org/wiki/Medical_weight_loss Medical weight loss on WikiMD] | |||
* [https://wikimd.org/wiki/GLP-1_weight_loss_injections GLP-1 weight loss injections on WikiMD] | |||
* [https://wikimd.org/wiki/Telemedicine Telemedicine on WikiMD] | |||
* [https://wikimd.org/wiki/Weight_loss_maintenance Weight loss maintenance on WikiMD] | |||
{{W8MD}} | |||
{{GLP-1}} | |||
{{DEFAULTSORT:Delaware Weight Loss}} | |||
[[Category:Delaware weight loss]] | |||
[[Category:Delaware]] | |||
[[Category:New Castle County, Delaware]] | |||
[[Category:Kent County, Delaware]] | |||
[[Category:Sussex County, Delaware]] | |||
[[Category:Greater Philadelphia weight loss]] | |||
[[Category:Philadelphia weight loss]] | |||
[[Category:Medical weight loss]] | |||
[[Category:Obesity medicine]] | |||
[[Category:W8MD]] | |||
[[Category:W8MD Weight Loss, Sleep and MedSpa]] | |||
[[Category:GLP-1 weight loss injections]] | |||
[[Category:GLP-1 weight loss]] | |||
[[Category:Semaglutide]] | |||
[[Category:Wegovy]] | |||
[[Category:Ozempic]] | |||
[[Category:Tirzepatide]] | |||
[[Category:Mounjaro]] | |||
[[Category:Zepbound]] | |||
[[Category:Diet pills]] | |||
[[Category:Phentermine]] | |||
[[Category:Contrave]] | |||
[[Category:Nutrition counseling]] | |||
[[Category:Meal replacements]] | |||
[[Category:Exercise counseling]] | |||
[[Category:Sleep apnea]] | |||
[[Category:Telemedicine]] | |||
[[Category:Weight loss maintenance]] | |||
[[Category:Weight regain]] | |||
[[Category:Insulin resistance]] | |||
[[Category:Prediabetes]] | |||
[[Category:Type 2 diabetes]] | |||
[[Category:Lifestyle medicine]] | |||
__NOTOC__ | |||